Furiex Pharmaceuticals Company Profile

16:20 EDT 1st August 2015 | BioPortfolio


News Articles [1 Associated News Articles listed on BioPortfolio]

Eluxadoline (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

LONDON, April 2, 2015 /PRNewswire/ -- SummaryIrritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a lif...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by adva...

Furiex Pharmaceuticals

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

More Information about "Furiex Pharmaceuticals" on BioPortfolio

We have published hundreds of Furiex Pharmaceuticals news stories on BioPortfolio along with dozens of Furiex Pharmaceuticals Clinical Trials and PubMed Articles about Furiex Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Furiex Pharmaceuticals Companies in our database. You can also find out about relevant Furiex Pharmaceuticals Drugs and Medications on this site too.


Advertisement
 
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record